<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>N-<z:chebi fb="9" ids="46887">acetyl</z:chebi>-beta-D-glucosaminidase (NAG) activity and isoenzyme profiles were studied in myeloid, histiocytic, B-lymphoid, T-lymphoid and lymphoblastoid continuous cell lines in order to determine if N-<z:chebi fb="9" ids="46887">acetyl</z:chebi>-beta-D-glucosaminidase isoenzyme expression may help to distinguish among various types of leukemic proliferation </plain></SENT>
<SENT sid="1" pm="."><plain>Total NAG activity in myeloid, histiocytic, erythroleukemic cell lines were higher than Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> derived cell lines (B-lymphoid), T- or lymphoblastoid cell lines </plain></SENT>
<SENT sid="2" pm="."><plain>On chromatofocusing by PBE 94 coupled with an automated enzyme assay an intermediate (I) beta-N-<z:chebi fb="9" ids="46887">acetyl</z:chebi>-glucosaminidase form, eluting between forms B and A, was found in <z:hpo ids='HP_0000001'>all</z:hpo> leukemic and in Epstein-Barr virus infected lymphoblastoid cell lines analysed </plain></SENT>
<SENT sid="3" pm="."><plain>The different profiles recorded, the expression of the I form and the different I/B ratios may be useful as markers of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> proliferation </plain></SENT>
</text></document>